BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 14, 2025
Breaking News: 100 days of uncertainty
Breaking News: 100 days of uncertainty
Breaking News: 100 days of uncertainty
Breaking News: 100 days of uncertainty
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
La Jolla Cancer Research Foundation claims mammalian trophinin
June 7, 1996
Zomacton, human growth hormone now available in Italy
June 7, 1996
Torii and Asahi Brewery report aldose reductase inhibitors
June 7, 1996
NN-42-1007: First potent and selective hepatic glycogen phosphorylase inhibitor
June 7, 1996
Sanguine's PHER-02 development
June 7, 1996
Amgen initiates first leptin clinical study
June 7, 1996
NO-1886 in phase II clinical trials
June 7, 1996
Sankyo discovers ACAT inhibitor
June 7, 1996
Hoescht reports imidobisphosphonic acid derivatives
June 7, 1996
Fujisawa claims ACAT inhibitors
June 7, 1996
Previous
1
2
…
1748
1749
1750
1751
1752
1753
1754
1755
1756
…
1762
1763
Next
RSS